Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer

Completed

Conditions studied: Breast Cancer, Prostate Cancer, Osteopenia, Osteoporosis

In brief

The investigators hypothesis is that secondary causes of bone loss are prevalent in patients with breast and prostate cancer, and those patients with secondary causes of bone loss are at higher risk for treatment related bone loss. The goals of this pilot study are to estimate the prevalence of secondary causes of osteoporosis in a cohort of patients with nonmetastatic breast and prostate cancer with osteopenia and osteoporosis.

Key facts

Study ID

NCT01277562

Run by

City of Hope Medical Center

People needed

56

Starts

2010-11-01

Expected to finish

2012-12-01

Last updated by the study team

2015-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of nonmetastatic breast cancer or diagnosis of nonmetastatic prostate cancer
• Measurement of bone mineral density by Dual Energy X-ray Absorptiometry (DEXA) within 6 months of enrollment into study.
• Patients of all ages are eligible but need to qualify for standard DEXA screening
• Patients of all performance status are eligible
• Patients are able to give informed consent

You may not qualify if…

• Patients previously diagnosed or treated for osteoporosis/osteopenia
• Stage IV cancer

Where it is running

• City of Hope Medical Center — Duarte, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.